Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Palisade Bio (PALI) Equity Ratio (2016 - 2025)

Palisade Bio has reported Equity Ratio over the past 16 years, most recently at 0.96 for Q4 2025.

  • Quarterly Equity Ratio rose 39.86% to 0.96 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.96 through Dec 2025, up 39.86% year-over-year, with the annual reading at 0.96 for FY2025, 39.86% up from the prior year.
  • Equity Ratio was 0.96 for Q4 2025 at Palisade Bio, up from 0.46 in the prior quarter.
  • Over five years, Equity Ratio peaked at 0.96 in Q4 2025 and troughed at 2.25 in Q1 2021.
  • The 5-year median for Equity Ratio is 0.7 (2024), against an average of 0.47.
  • Year-over-year, Equity Ratio crashed 149.94% in 2021 and then skyrocketed 217.25% in 2022.
  • A 5-year view of Equity Ratio shows it stood at 0.59 in 2021, then surged by 34.49% to 0.79 in 2022, then grew by 1.69% to 0.81 in 2023, then fell by 14.47% to 0.69 in 2024, then surged by 39.86% to 0.96 in 2025.
  • Per Business Quant, the three most recent readings for PALI's Equity Ratio are 0.96 (Q4 2025), 0.46 (Q3 2025), and 0.39 (Q2 2025).